Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Agriculture. Transforming U.S. agriculture.

Reganold JP, Jackson-Smith D, Batie SS, Harwood RR, Kornegay JL, Bucks D, Flora CB, Hanson JC, Jury WA, Meyer D, Schumacher A Jr, Sehmsdorf H, Shennan C, Thrupp LA, Willis P.

Science. 2011 May 6;332(6030):670-1. doi: 10.1126/science.1202462. No abstract available.

PMID:
21551050
2.

The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.

Bucks D, Sarpotdar P, Yu K, Angel A, Del Rosso J.

J Drugs Dermatol. 2009 Jul;8(7):634-8.

PMID:
19588639
3.

Blockage of skin invasion by schistosome cercariae by serine protease inhibitors.

Lim KC, Sun E, Bahgat M, Bucks D, Guy R, Hinz RS, Cullander C, McKerrow JH.

Am J Trop Med Hyg. 1999 Mar;60(3):487-92.

PMID:
10466982
5.

Topical delivery system for tretinoin: research and clinical implications.

Skov MJ, Quigley JW, Bucks DA.

J Pharm Sci. 1997 Oct;86(10):1138-43.

PMID:
9344171
6.

An unexpected finding in percutaneous absorption observed between haired and hairless guinea pig skin.

Hisoire G, Bucks D.

J Pharm Sci. 1997 Mar;86(3):398-400. No abstract available.

PMID:
9050813
7.
8.

Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo.

Kameyama K, Sakai C, Kondoh S, Yonemoto K, Nishiyama S, Tagawa M, Murata T, Ohnuma T, Quigley J, Dorsky A, Bucks D, Blanock K.

J Am Acad Dermatol. 1996 Jan;34(1):29-33.

PMID:
8543691
9.

Human in vivo percutaneous absorption of pyrethrin and piperonyl butoxide.

Wester RC, Bucks DA, Maibach HI.

Food Chem Toxicol. 1994 Jan;32(1):51-3.

PMID:
8132164
10.

Uptake of two zwitterionic surfactants into human skin in vivo.

Bucks DA, Hostynek JJ, Hinz RS, Guy RH.

Toxicol Appl Pharmacol. 1993 Jun;120(2):224-7.

PMID:
8511791
11.

In vivo percutaneous absorption of hydrocortisone: multiple-application dosing in man.

Melendres JL, Bucks DA, Camel E, Wester RC, Maibach HI.

Pharm Res. 1992 Sep;9(9):1164-7.

PMID:
1409398
12.

Percutaneous absorption and skin decontamination of PCBs: in vitro studies with human skin and in vivo studies in the rhesus monkey.

Wester RC, Maibach HI, Bucks DA, McMaster J, Mobayen M, Sarason R, Moore A.

J Toxicol Environ Health. 1990 Dec;31(4):235-46.

PMID:
2254950
13.

Topical corticosteroid compounding.

Oriba HA, Bucks DA.

J Am Acad Dermatol. 1990 Nov;23(5 Pt 1):954. No abstract available.

PMID:
2254493
14.

Percutaneous absorption of [14C]DDT and [14C]benzo[a]pyrene from soil.

Wester RC, Maibach HI, Bucks DA, Sedik L, Melendres J, Liao C, DiZio S.

Fundam Appl Toxicol. 1990 Oct;15(3):510-6.

PMID:
2258015
15.

In vivo percutaneous absorption of fragrance ingredients in rhesus monkeys and humans.

Bronaugh RL, Wester RC, Bucks D, Maibach HI, Sarason R.

Food Chem Toxicol. 1990 May;28(5):369-73.

PMID:
2379896
16.

In vivo percutaneous absorption of chemicals: a multiple dose study in rhesus monkeys.

Bucks DA, Hinz RS, Sarason R, Maibach HI, Guy RH.

Food Chem Toxicol. 1990 Feb;28(2):129-32.

PMID:
2341090
17.

In vitro percutaneous absorption and stratum corneum binding of alachlor: effect of formulation dilution with water.

Bucks DA, Wester RC, Mobayen MM, Yang D, Maibach HI, Coleman DL.

Toxicol Appl Pharmacol. 1989 Sep 15;100(3):417-23.

PMID:
2781567
18.

Paraquat poisoning by skin absorption.

Wester RC, Mailbach HI, Bucks DA.

Hum Toxicol. 1989 May;8(3):251-2. No abstract available.

PMID:
2744784
19.

Bioavailability of topically administered steroids: a "mass balance" technique.

Bucks DA, McMaster JR, Maibach HI, Guy RH.

J Invest Dermatol. 1988 Jul;91(1):29-33.

20.

Mass balance and dose accountability in percutaneous absorption studies: development of a nonocclusive application system.

Bucks DA, Maibach HI, Guy RH.

Pharm Res. 1988 May;5(5):313-5. No abstract available.

PMID:
3244642
22.

Skin absorption from patch test systems.

Kim HO, Wester RC, McMaster JA, Bucks DA, Maibach HI.

Contact Dermatitis. 1987 Sep;17(3):178-80.

PMID:
3677660
23.

Transdermal drug delivery and cutaneous metabolism.

Guy RH, Hadgraft J, Bucks DA.

Xenobiotica. 1987 Mar;17(3):325-43. Review.

PMID:
3107225
24.

Percutaneous penetration of nicotinates: in vivo and in vitro measurements.

Guy RH, Carlström EM, Bucks DA, Hinz RS, Maibach HI.

J Pharm Sci. 1986 Oct;75(10):968-72.

PMID:
3795027
25.

Effect of repeated skin administration on in vivo percutaneous absorption of drugs.

Courtheoux S, Pechenot D, Bucks DA, Marty JP, Maibach HI, Wepierre J.

Br J Dermatol. 1986 Aug;115 Suppl 31:49-52. No abstract available.

PMID:
3741801
26.

Percutaneous absorption of steroids: effect of repeated application.

Bucks DA, Maibach HI, Guy RH.

J Pharm Sci. 1985 Dec;74(12):1337-9. No abstract available.

PMID:
4087204
27.

Percutaneous absorption of malathion in the guinea-pig: effect of repeated topical application.

Bucks DA, Marty JP, Maibach HI.

Food Chem Toxicol. 1985 Oct;23(10):919-22.

PMID:
4065766
28.

Comparison of percutaneous absorption of fragrances by humans and monkeys.

Bronaugh RL, Stewart RF, Wester RC, Bucks D, Mailbach HI, Anderson J.

Food Chem Toxicol. 1985 Jan;23(1):111-4.

PMID:
4038674
29.

Skin structure and metabolism: relevance to the design of cutaneous therapeutics.

Bucks DA.

Pharm Res. 1984 Jul;1(4):148-53. doi: 10.1023/A:1016340423079.

PMID:
24277282
30.

In vivo percutaneous absorption of paraquat from hand, leg, and forearm of humans.

Wester RC, Maibach HI, Bucks DA, Aufrere MB.

J Toxicol Environ Health. 1984;14(5-6):759-62.

PMID:
6520886
31.

Lindane binding to sections of human skin: skin capacity and isotherm determinations.

Menczel E, Bucks D, Maibach H, Wester R.

Arch Dermatol Res. 1984;276(5):326-9.

PMID:
6207781
32.

Benzoyl peroxide: percutaneous penetration and metabolic disposition. II. Effect of concentration.

Yeung D, Nacht S, Bucks D, Maibach HI.

J Am Acad Dermatol. 1983 Dec;9(6):920-4.

PMID:
6643790
33.

Polychlorinated biphenyls (PCBs): dermal absorption, systemic elimination, and dermal wash efficiency.

Wester RC, Bucks DA, Maibach HI, Anderson J.

J Toxicol Environ Health. 1983 Oct-Dec;12(4-6):511-9.

PMID:
6422047
34.

In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers.

Wester RC, Bucks DA, Maibach HI.

J Am Acad Dermatol. 1983 May;8(5):645-7.

PMID:
6863620
35.

Malathion percutaneous absorption after repeated administration to man.

Wester RC, Maibach HI, Bucks DA, Guy RH.

Toxicol Appl Pharmacol. 1983 Mar 30;68(1):116-9.

PMID:
6845371
36.

Malathion binding to sections of human skin: skin capacity and isotherm determinations.

Menczel E, Bucks D, Maibach H, Wester R.

Arch Dermatol Res. 1983;275(6):403-6.

PMID:
6660913
37.

Percutaneous penetration of hydrocortisone in humans following skin delipidization by 1:1:1 trichloroethane.

Bucks DA, Maibach HI, Menczel E, Wester RC.

Arch Dermatol Res. 1983;275(4):242-5.

PMID:
6625650
38.

Selective release of extrahepatic lipoprotein lipase by polymetaphosphate.

Felts JM, Bucks DA.

Biochem Biophys Res Commun. 1981 Oct 15;102(3):1034-40. No abstract available.

PMID:
7306186
39.

Measurement of low level carbon-14 in biologic specimens by wet ashing.

Bucks D, Maibach H.

Arch Dermatol Res. 1981;271(3):241-4. No abstract available.

PMID:
7305439

Supplemental Content

Support Center